Device shows potential in preventing stroke by blocking clots

10/3/2013 | Charleston Regional Business Journal (S.C.)

PMG Research is conducting a clinical trial comparing the effectiveness of St. Jude Medical's Amplatzer cardiac plug, an anti-clotting device, to anticoagulant therapy. The device is inserted into a patient's leg via catheter and blocks part of the heart to keep clots from flowing into the bloodstream. Researcher Dr. Matthew O'Steen said the Amplatzer shows promise in stroke prevention.

View Full Article in:

Charleston Regional Business Journal (S.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX